F1543

Ammonium iron(II) sulfate hexahydrate

BioXtra, ≥98%

• Sinónimos: Ammonium ferrous sulfate hexahydrate, Ammonium iron(II) sulfate, Mohr’s salt
• Fórmula lineal: (NH₄)₂Fe(SO₄)₂ · 6H₂O
• Número de CAS: 7783-85-9
• Peso molecular: 392.14
• EC Number: 233-151-8
• MDL number: MFCD00150530
• UNSPSC Code: 12161700
• PubChem Substance ID: 24894782
• NACRES: NA.25

Propiedades

• product line: BioXtra
• Quality Level: 200
• assay: ≥98%
• reaction suitability: reagent type: catalyst; core: iron
• impurities: ≤0.0005% Phosphorus (P); ≤0.01% Insoluble matter
• mp: 100 °C (dec.) (lit.)
• solubility: dilute sulfuric acid: 1 M
• cation traces: Al: ≤0.001%; Ca: ≤0.0005%; Cu: ≤0.005%; K: ≤0.005%; Mg: ≤0.002%; Mn: ≤0.01%; Na: ≤0.005%; Pb: ≤0.001%; Zn: ≤0.001%
• SMILES string: N.N.O.O.O.O.O.O.[Fe++].OS([O-])(=O)=O.OS([O-])(=O)=O
• InChI: 1S/Fe.2H3N.2H2O4S.6H2O/c;;;2*1-5(2,3)4;;;;;;/h;2*1H3;2*(H2,1,2,3,4);6*1H2/q+2;;;;;;;;;;/p-2
• InChI key: MQLVWQSVRZVNIP-UHFFFAOYSA-L

Descripción

Application

• pH responsive controlled release of anti-cancer hydrophobic drugs from sodium alginate and hydroxyapatite bi-coated iron oxide nanoparticles.: This study explores the use of ammonium iron(II) sulfate hexahydrate in the synthesis of bi-coated iron oxide nanoparticles for pH-responsive controlled drug release. The nanoparticles, coated with sodium alginate and hydroxyapatite, were designed for the controlled release of hydrophobic anti-cancer drugs, demonstrating significant potential for targeted cancer therapy applications (Manatunga et al., 2017).

Información de seguridad

• Storage Class: 13 - Non Combustible Solids
• wgk_germany: WGK 1
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• ppe: dust mask type N95 (US), Eyeshields, Gloves